The world's first Extended Isolated Stopflow Limb Infusion (EISLI) to treat osteosarcoma results in complete remission
more
Stories about Medizin
- Language:
- Media:
- Period:
- Period:Total
DEBIOPHARM EXTENDS THEIR DNA DAMAGE REPAIR FOOTPRINT WITH NEW ONCOLOGY PIPELINE ENTRY
Lausanne, Switzerland (ots) - Debiopharm obtains global rights from Novo Nordisk for the development of their ubiquitin-specific protease 1 (USP1) inhibitor Debiopharm (www.debiopharm.com), an independent Swiss-based, biopharmaceutical company aiming to develop tomorrow’s standard-of-care treatments to cure cancer and infectious diseases, today announced having ...
moreSuccessful transaction: Adragos Pharma has officially taken over the Sanofi production site in Kawagoe, Japan
Munich / Paris / Tokyo (ots) - - Adragos Pharma now third largest pure-play CDMO in the Japanese market - Long-term agreement with Sanofi secures local healthcare supply Munich-based pharmaceutical contract manufacturer (CDMO) Adragos Pharma GmbH successfully completed the acquisition of one of Japan's leading ...
moreNew study from Waltham Petcare Science Institute, part of Mars Petcare, shows cannabidiol (CBD) is effective at reducing stress in dog
WALTHAM-ON-THE-WOLDS, England (ots/PRNewswire) - - Single dose of THC-free CBD reduced stress in healthy dogs - The study, conducted by the Waltham Petcare Science Institute, was published today in Frontiers in Veterinary Science. Results from a study performed by the Waltham Petcare Science Institute published ...
moreMadeira's public health service SESARAM, EPERAM cooperates with EU project Smart4Health
Potsdam (Germany) (ots) - - Over 260,000 residents and travelers to Madeira Islands can use the digital health solution free of charge - Easy access to healthcare data from the public healthcare services, via a European electronic health record - the Smart4Health platform The Public Health Service of the Autonomous Region of Madeira - SESARAM, EPERAM - has successfully ...
moreBreakthrough - EUR 50 million investment for start-up BrainRepair UG / Pivotal trial on stem cell treatment for brain damage in newborns fully funded
more
Accord Healthcare marks World Cancer Day 2023 appearing in ITN Business news-style programme Working Together: To Tackle Cancer
London (ots/PRNewswire) - Accord Healthcare (Accord), one of Europe's fastest growing pharmaceutical companies, marks World Cancer Day 2023 today by taking part in news-style programme for ITN Business alongside other partners from industry and the patient community to raise awareness of the importance of working ...
moreStem cell therapy for “Butterfly disease” / RHEACELL receives ‘Partners in Progress Award’ from debra of America for Epidermolysis Bullosa research
moreMetrics in Balance und DNA Talks schließen sich zusammen und betreten den europäischen Lifestyle-Markt unter einem neuen Namen: LifeTalks
moreKlinik für Prostata-Therapie Heidelberg
Focal therapy for prostate cancer: Reliable diagnosis leads to gentle treatment
morebenfovir AG has reached another milestone by completing the first part of the Phase 1 trial testing transketolase inhibitor / benfo-oxythiamine (B-OT)
Darmstadt (ots) - benfovir AG, a German pharmaceutical company focused on developing small molecules against viral infections such as SARS-CoV-2, dengue and herpes virus, today announced that the first part of the Phase 1 clinical trial (BV-01-101/ EudraCT Number: 2021-005616-60.) designed to evaluate the safety, ...
moreAS&K Group rebrands as Scientific Group / Move reflects new company vision and brings full-service offering under a unified structure
London, UK (ots) - Leading independent Medical Communications company, AS&K Group, has undergone a rebrand, changing its name to Scientific Group. The move comes a year after the Group celebrated its 25th anniversary and acts to bring its three entities - AS&K Communications, The Corpus and Remedica Communications - ...
more
European Society for Medical Oncology (ESMO)
ESMO 2022 - Great oaks grow from small acorns: oncology is committed to doing its part for sustainability
Paris (ots) - At ESMO 2022, 9-13 September, Paris, France, the premier cancer congress in Europe, which has gathered 28k participants from 167 countries, many discussions will be around sustainability, prevention and novel approaches which could soon become a reality in the clinic. - Late-breaking results elucidate ...
moreR-Biopharm starts commercialization of the fully automated RIDA®UNITY system for real-time PCR in molecular diagnostic laboratories
moreR-Biopharm is IVDR certified
morebenfovir Announces First Subjects Dosed in Phase 1 Clinical Trial of B-OT/ B-OT IS BEING DEVELOPED FOR THE TREATMENT OF VIRAL INFECTIONS
Darmstadt (ots) - benfovir AG has reached another major milestone by moving its first compound into clinical development with the start of a Phase 1 testing B-OT in healthy volunteers. benfovir AG, a German pharmaceutical biotechnology company focused on developing small molecules against viral infection such as ...
more- 2
R-Biopharm acquires Australian lab equipment manufacturer and molecular biology multiplex specialist AusDiagnostics
more R-Biopharm announces test to detect monkeypox virus
more
- 2
World's first electronic respirator sterilising (corona)-viruses of all variants completely by UV-LED-radiation-effected RNA destruction
more HPDC Launches the World’s First All-in-One Supply Chain Management Solution for Advanced & Personalized Therapies
Munich/Nice (ots) - Hypertrust Patient Data Care (HPDC) today announced the global launch of its extended Hypertrust X-Chain supply chain management solution for Advanced & Personalized Therapies (APT). It is the worldwide first solution that allows biotech and pharmaceutical companies to design, set up, plan, ...
moreEndoscopic surgery of herniated discs demonstrates statistically significant pain relief and cost effectiveness compared to open procedures
Munich (ots) - A team of physicians, led by neurosurgeon Dr. B.S. Harhangi from Erasmus Medical Center in Rotterdam, recently published a study demonstrating considerable relief for patients with herniated discs after using the MaxMoreSpine© System. For the first time, a scientific study compares outcome and ...
more- 2
Exclusive Health & Safety Partner of the Munich Security Conference 2022: EcoCare commissioned to carry out daily COVID-19 tests on top politicians and diplomats
more Legalization debate in Germany: Cannabis expert Cannify becomes Enua Pharma GmbH / The start-up has been on the market for four years and is now one of the largest cannabis retailers in Germany
moreUniversity of Chicago Clinical Trial Utilizes Sysmex Inostics Highly Effective HPV-SEQ Test to Measure HPV-DNA from Blood of Neck and Throat Cancer Patients
Baltimore, MD (ots) - Sysmex Inostics, a global leader in the liquid biopsy revolution for oncology, announces the use of their HPV-SEQ test in the prospective University of Chicago clinical trial,1 “Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer.” “The ability to reliably detect HPV-DNA ...
more
Digital health platform helps to expand conventional medical services / EvoCare invites investors to support global roll-out
moreNew therapeutic approach against SARS-CoV-2 successfully tested
Pfungstadt (ots) - - Scientists at the Universities of Frankfurt a.M. and Kent (UK) have identified a metabolic pathway (pentose-phosphate pathway) that is crucial for the propagation of the SARS-CoV-2 virus in human cells. - The compound benfo-oxythiamine, an inhibitor of this metabolic pathway, has succeeded in blocking the replication of the SARS-CoV-2 virus in human cells. - Preclinical testing of this compound has ...
more- 2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation
more CHRISTMAS COMES EARLY FOR CHILDREN WITH CANCER COURTESY OF PM-INTERNATIONAL MALAYSIA
moreArtificial intelligence in the healthcare sector: Lindera successfully closes financing round of six million euros
moreAlmirall delivers solid nine months 2021 results and tightens its upgraded guidance
Barcelona, Spain (ots/PRNewswire) - - Strong Core business performance with growth in Core Net Sales EUR601.7 MM (+6.2% year-on-year) and Core EBITDA reaching EUR164.2 MM, (+20.3% year-on-year) driven by positive contribution from Growth Drivers and a strong EU dermatology performance - Key Growth Drivers underpinning increase in Core Net Sales. Strong performance from ...
more
Previous12345678Next